Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study.
about
Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studiesHearing and dementia.The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.Review of brief cognitive tests for patients with suspected dementia.A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer's disease.Memory banking: a life story intervention for aging preparation and mental health promotionDementia=(MC)2: a 4-item screening test for mild cognitive impairment and dementiaThe relationships between body composition characteristics and cognitive functioning in a population-based sample of older British menCohort Profile Update: The British Regional Heart Study 1978-2014: 35 years follow-up of cardiovascular disease and ageing.Cognitive Impairment in Diabetes: Rationale and Design Protocol of the Cog-ID Study.Assessing the Construct Validity and Internal Reliability of the Screening Tool Test Your Memory in Patients with Chronic PainComparing diagnostic accuracy of cognitive screening instruments: a weighted comparison approach.The Test Your Memory cognitive screening tool: sociodemographic and cardiometabolic risk correlates in a population-based study of older British men.Picture-based memory impairment screen for dementia.Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's DiseaseThe validity of the Memory Alteration Test and the Test Your Memory test for community-based identification of amnestic mild cognitive impairment.Detection of mild cognitive impairment and early stage dementia with an audio-recorded cognitive scale.The death knoll for the MMSE: has it outlived its purpose?The role of olfactory challenge tests in incipient dementia and clinical trial design.The use and misuse of short cognitive tests in the diagnosis of dementia.Cognitive screening in persons with chronic diseases in primary care: challenges and recommendations for practice.Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment.Heading in football, long-term cognitive decline and dementia: evidence from screening retired professional footballers.Performance-Based Cognitive Screening Instruments: An Extended Analysis of the Time versus Accuracy Trade-off.Patient Satisfaction and Short-Term Outcome in Elective Cranial Neurosurgery.DemTect®--effective to asses MCI and dementia--validation study of the Polish language version.Assessment scales in dementia.The Q* Index: A Useful Global Measure of Dementia Screening Test Accuracy?Effect Size (Cohen's d) of Cognitive Screening Instruments Examined in Pragmatic Diagnostic Accuracy StudiesCobalamin status and its relation with depression, cognition and neuropathy in patients with type 2 diabetes mellitus using metformin.Test Your Memory (TYM) as a screening instrument in clinical practice - the Polish validation study.Age-related differences in processing face configuration: the importance of the eye region.Comparison of 2 dementia screeners, the Test Your Memory Test and the Mini-Mental State Examination, in a primary care setting.Test Your Memory test, Arabic version: is it practical in a different culture?The Test Your Memory for Mild Cognitive Impairment (TYM-MCI).Cognitive screening tools for primary care settings: examining the 'Test Your Memory' and 'General Practitioner assessment of Cognition' tools in a rural aging population in Greece.Cultural adaptation, standardization and clinical validity of the test your memory dementia screening instrument in Greek.Simple Preoperative Patient-Reported Factors Predict Adverse Outcome After Elective Cranial Neurosurgery.Letter: Simple Preoperative Patient-Reported Factors Predict Adverse Outcome After Elective Cranial Neurosurgery.Case-finding for cognitive impairment among people with Type 2 diabetes in primary care using the Test Your Memory and Self-Administered Gerocognitive Examination questionnaires: the Cog-ID study.
P2860
Q24200257-52EDB1E0-A8D3-40CD-9453-9165F43C0C1EQ30249183-834E55C7-72E7-432C-9FEC-8757C9AE9A74Q31145409-FE314029-19F6-4950-83B3-A7174587DB2EQ33810412-8849976A-EBCB-48FD-9687-85F59D145605Q34630555-F2548554-0420-4475-BD80-0CBDB98A532FQ35088657-2A71004C-E509-4D0C-896D-4AC56D4CA5F8Q35167013-53A4E646-7981-4589-B35D-96BB62DEF68FQ35875046-7D5E405A-78C9-420E-8C61-3581C0E79733Q35905656-9F713597-7E40-4737-8DC5-8690C96703BDQ35922316-A2C9063C-65A7-423A-AE6D-47356FAE2328Q36000565-1241CFD8-039A-432B-A013-79449DE950DCQ36744317-8C86B533-B797-448F-AFDB-C0D4CD1E4482Q36866365-B455ACF4-23FC-478F-9BEF-25BFB368A275Q36921999-E0CA0194-F5A4-4BBE-9323-9F4B1C1DFE94Q37104768-5CF597CB-E330-4710-A22E-D2867C557F7AQ37252592-58AE198A-9474-4CA0-8F1F-B88F09A6A038Q37677407-CCBAD673-277D-45CD-8124-318C47DD459EQ37709818-1FF02D97-8B69-40C5-BAE5-D1D2E65C3C61Q38232900-D1027148-ED84-4741-911F-4A6370DFFF9DQ38269851-CB497DBC-E681-493F-85B0-534E589AC604Q38385596-46F4B9E4-06E4-44CF-BE30-0DF34A6DDA64Q38476020-FBFFAF22-2D17-492D-ADB6-3D90C4AADFFDQ39351955-9A09E462-64EA-4B6F-B79F-AB74405530F3Q40015948-27BF7B9F-D28B-430F-8FF0-3671E163B81AQ41071323-7A01B6F0-3DB6-4DDA-A9E8-ADE5D32583A4Q41155948-D1504F5D-26A7-408E-8299-BAFABE3B1B28Q41539723-005D43CE-4EBE-40CC-B31D-10E08661A069Q41652410-90276F55-32BC-402D-91C0-B3D7D094043AQ42200751-B29883A7-0E42-45C0-AECC-C5542AC81333Q43596928-F44E6E59-B25D-48E8-B522-F5E72ECF8FC4Q43771036-FCC6F119-CB60-476F-AC02-24285C8BED2DQ44289829-5152F13A-E389-4736-8963-ABA536132157Q46175535-6D23020B-CAC5-4960-A1A2-94DC676824A6Q46884674-4D92E3FF-E719-46B7-B159-0E252E37362CQ47139185-9376D030-CE55-46AB-88E8-447B84ECCA59Q47696635-C030543D-5222-481C-AA2A-3CBC0D4C7B46Q48409540-195F51CA-7213-4F68-8D44-46072B696F0DQ49842785-DD3A41F2-9F5F-4887-A53E-697E21383AAEQ50081024-41E885B9-BBA1-49D5-BB87-3EF86D16E542Q50576142-1D772368-EE4A-436C-A854-5CE880AC308B
P2860
Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Self administered cognitive sc ...... isease: cross sectional study.
@en
Self administered cognitive screening test
@nl
type
label
Self administered cognitive sc ...... isease: cross sectional study.
@en
Self administered cognitive screening test
@nl
prefLabel
Self administered cognitive sc ...... isease: cross sectional study.
@en
Self administered cognitive screening test
@nl
P2093
P2860
P356
P1433
P1476
Self administered cognitive sc ...... disease: cross sectional study
@en
P2093
George Pengas
Jeremy Brown
Kate Dawson
Lucy A Brown
P2860
P356
10.1136/BMJ.B2030
P407
P577
2009-06-09T00:00:00Z